Latest Research from Nixon Lab Suggests Rab5 Overactivation as a Potential Therapeutic Target
New York – New research from the lab of CDR Director, Ralph Nixon, is published in an open access paper in Cell Reports. The article, titled “Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer’s,” is the result of research by lead author Dr. Anna Pensalfini and other collaborators from the CDR and NKI.